Madrid, Spain

Blanca Ocana


Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 1997

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Blanca Ocana in Antitumoral Compounds

Introduction

Blanca Ocana is a notable inventor based in Madrid, Spain. She has made significant contributions to the field of medicinal chemistry, particularly in the development of antitumoral compounds. Her work focuses on innovative solutions to combat cancer, showcasing her dedication to improving healthcare through scientific research.

Latest Patents

Blanca Ocana holds a patent for antitumoral compounds, specifically Azaanthracene-triones of the formula: ##STR1##. This invention represents a promising advancement in cancer treatment, as it explores the potential of these compounds to inhibit tumor growth effectively. The patent highlights her commitment to addressing critical health challenges through innovative chemical solutions.

Career Highlights

Blanca Ocana is affiliated with the Universidad Complutense de Madrid, where she conducts her research and collaborates with fellow scientists. Her academic background and research endeavors have positioned her as a key figure in her field. With a focus on antitumoral research, she continues to contribute to the scientific community and advance the understanding of cancer therapies.

Collaborations

Throughout her career, Blanca has worked alongside esteemed colleagues, including Carmen Avendano and Miguel A Alonso. These collaborations have enriched her research and fostered a collaborative environment that encourages innovation and discovery.

Conclusion

Blanca Ocana's work in developing antitumoral compounds exemplifies her commitment to advancing cancer treatment. Her innovative research and collaborations with fellow scientists highlight the importance of teamwork in achieving breakthroughs in medicine. Through her contributions, she continues to inspire future generations of inventors and researchers.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…